Trials / Completed
CompletedNCT02090179
Evaluation of Blood Brain Barrier Integrity and Structural Abnormalities in MPS IIIB Patients Using Multimodal Magnetic Resonance Imaging
Evaluation of Blood Brain Barrier Integrity and Relationship to Structural Brain Abnormalities in MPS IIIB Patients Using Cerebrospinal Fluid/Serum Albumin Index (CSF-AI) and Multimodal Magnetic Resonance Imaging
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to characterize structural abnormalities in the brain and the integrity of the blood brain barrier in patients with mucopolysaccharidosis type IIIB (MPS IIIB).
Conditions
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-03-18
- Last updated
- 2016-06-27
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02090179. Inclusion in this directory is not an endorsement.